Inflazyme Pharmaceuticals Ltd. (TSX:IZP) sold substantially all of its research and development assets to Biolipox AB


DRUG DEVELOPMENT
THERAPEUTICS

Visit bctech for more information about Inflazyme Pharmaceuticals.